C9024 – Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine

Long description

Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine

Short description

Inj, daunorubicin-cytarabine

Pricing indicator

53 Statute

Medicare coverage

D Special coverage instructions apply

BETOS category

O1D Chemotherapy

Cross reference

J9153

Added

January 1, 2018

Last change

January 1, 2019 – No change

Termination date

December 31, 2018

Nearby C codes

• C8937 – Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)
• C8957 – Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
• C9014 – Injection, cerliponase alfa, 1 mg
• C9015 – Injection, c-1 esterase inhibitor (human), haegarda, 10 units
• C9016 – Injection, triptorelin extended release, 3.75 mg
• C9021 – Injection, obinutuzumab, 10 mg
• C9022 – Injection, elosulfase alfa, 1mg
• C9023 – Injection, testosterone undecanoate, 1 mg
• C9025 – Injection, ramucirumab, 5 mg
• C9026 – Injection, vedolizumab, 1 mg
• C9027 – Injection, pembrolizumab, 1 mg
• C9028 – Injection, inotuzumab ozogamicin, 0.1 mg
• C9029 – Injection, guselkumab, 1 mg
• C9030 – Injection, copanlisib, 1 mg
• C9031 – Lutetium lu 177, dotatate, therapeutic, 1 mci
• C9032 – Injection, voretigene neparvovec-rzyl, 1 billion vector genome